(Q38886304)

7 September 2017

title

ATM kinase sustains HER2 tumorigenicity in breast cancer (English)

1 reference

7 September 2017

4

Marcella Mottolese

0 references

author name string

Venturina Stagni

1

1 reference

7 September 2017

Isabella Manni

2

1 reference

7 September 2017

Veronica Oropallo

3

1 reference

7 September 2017

Marcella Mottolese

4

1 reference

7 September 2017

Anna Di Benedetto

5

1 reference

7 September 2017

Giulia Piaggio

6

1 reference

7 September 2017

Rita Falcioni

7

1 reference

7 September 2017

Danilo Giaccari

8

1 reference

7 September 2017

Selene Di Carlo

9

1 reference

7 September 2017

Francesca Sperati

10

1 reference

7 September 2017

Maria Teresa Cencioni

11

1 reference

7 September 2017

Daniela Barilà

12

1 reference

7 September 2017

language of work or name

English

0 references

publication date

16 April 2015

1 reference

7 September 2017

published in

Nature Communications

1 reference

7 September 2017

volume

6

1 reference

7 September 2017

page(s)

6886

1 reference

The ATM protein kinase: regulating the cellular response to genotoxic stress, and more

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis: the DSB connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ATM gene and lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Ataxia telangiectasia gene mutations in leukaemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Breast and other cancers in families with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Cancer risks and mortality in heterozygous ATM mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Rare variants in the ATM gene and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Dual roles of ATM in the cellular response to radiation and in cell growth control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Pathological neoangiogenesis depends on oxidative stress regulation by ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Mitochondrial dysfunction in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

EGF-ERBB signalling: towards the systems level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

DNA damage signalling guards against activated oncogenes and tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

A metabolic prosurvival role for PML in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Oxygen sensing is impaired in ATM-defective cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

The cooperation between hMena overexpression and HER2 signalling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Abl interconnects oncogenic Met and p53 core pathways in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Silencing the MET oncogene leads to regression of experimental tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

Treatment of HER2-overexpressing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7886

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCOMMS7886

1 reference

Dimensions Publication ID

7 September 2017

0 references

1028971232

0 references

1 reference